Press Releases

WASHINGTON – Today, USAgainstAlzheimer’s launched LatinosAgainstAlzheimer’s, the nation’s first-ever coalition of Latino organizations focused on raising awareness of Alzheimer's as an urgent health issue within the Latino community.

WASHINGTON – With the projected growth of Alzheimer’s disease and the dramatic growth of the Latino population, Alzheimer’s poses a serious threat to the health and well-being of the Latino community, the nation’s largest minority group.

As the Alzheimer’s epidemic grows, it is critical for policymakers, healthcare service providers, and community stakeholders to understand and address the unique challenges that the disease poses to the Latino community via targeted research, policy solutions, and increased community awareness and engagement.

Washington, DC – The 2015 government spending package, known as the ‘cromnibus,’ includes an increase of $25 million for the National Institute on Aging (NIA), with an expectation that much of the funding would support additional research into Alzheimer’s and dementia.

Washington, DC – Seasons of Caring: Meditations for Alzheimer’s and Dementia Caregivers (available from CreateSpace) is a book for anyone who loves and cares for someone with Alzheimer’s or dementia. Seasons of Caring contains more than 140 original meditations from faith leaders and care specialists representing a wide and diverse range of major religious traditions, including Baptist, Buddhist, Catholic, Jewish, Lutheran, Methodist, Muslim, Presbyterian, Sikh and Unitarian Universalist among others.

Lausanne, Switzerland – There is currently no cure for Alzheimer’s disease and other dementias. The main barriers to the development of effective treatments for Alzheimer’s disease are an incomplete understanding of the disease, fragmented resources, and challenges with the design and implementation of clinical trials.  Experts gathered at a two day meeting in Lausanne to discuss future steps to address dwindling product pipelines and to increase the productivity of drug development processes.

Pages

^ Back to Top